Docetaxel/Trastuzumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of docetaxel and trastuzumab that may be used in the treatment of breast, esophageal and esophagogastric junction, and gastric cancers and salivary gland tumors. Docetaxel every 21 days plus trastuzumab regimen may be used for the treatment of breast cancer.

**Synonyms:** - Docetaxel and Trastuzumab (TH) - Docetaxel and Trastuzumab-anns (TH) - Docetaxel and Trastuzumab-dkst (TH) - Docetaxel and Trastuzumab-dttb (TH) - Docetaxel and Trastuzumab-herw (TH) - Docetaxel and Trastuzumab-pkrb (TH) - Docetaxel and Trastuzumab-qyyp (TH) - Docetaxel and Trastuzumab-zerc (TH) - Docetaxel-Trastuzumab - Docetaxel-Trastuzumab Regimen - Docetaxel/Trastuzumab - T-H (Docetaxel) - T-H (Docetaxel) (trastuzumab-anns) - T-H (Docetaxel) (trastuzumab-dkst) - T-H (Docetaxel) (trastuzumab-dttb) - T-H (Docetaxel) (trastuzumab-herw) - T-H (Docetaxel) (trastuzumab-pkrb) - T-H (Docetaxel) (trastuzumab-qyyp) - T-H (Docetaxel) (trastuzumab-strf) - T-H (Docetaxel) (trastuzumab-zerc) - Taxotere/Herceptin